Individual treatment for malignant melanoma
- 1 January 1989
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 40 (1) , 46-48
- https://doi.org/10.1002/jso.2930400111
Abstract
Much has been learned in the recent decade about the predictable biologic behavior of cutaneous malignant melanoma. Indeed, such knowledge permits highly individualized treatment based on simple demographic data on the patient, location of the lesion, and its thickness according to the Breslow scale. The thoughtful surgeon may individualize his treatment according to the likely biologic behavior of the tumor, minimizing treatment morbidity while maintaining optimum results from primary and secondary surgical treatment.Keywords
This publication has 11 references indexed in Scilit:
- MALIGNANT MELANOMA: THE AUSTRALIAN CONTRIBUTIONAnz Journal of Surgery, 1988
- A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant MelanomaAnnals of Surgery, 1984
- The Extent of Primary Melanoma ExcisionAnnals of Surgery, 1983
- Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusionCancer, 1983
- The Treatment of Stage I Melanoma of the Extremities with Regional Hyperthermic Isolation PerfusionAnnals of Surgery, 1982
- Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: Results of surgical treatment in 1319 patientsBritish Journal of Surgery, 1982
- A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary resultsCancer, 1978
- Inefficacy of Immediate Node Dissection in Stage 1 Melanoma of the LimbsNew England Journal of Medicine, 1977
- Tumor Thickness, Level of Invasion and Node Dissection in Stage I Cutaneous MelanomaAnnals of Surgery, 1975
- Selective Regional Lymphadenectomy for MelanomaAnnals of Surgery, 1971